Fast and slow-twitching muscles are differentially affected by reduced cholinergic transmission in mice deficient for VAChT: A mouse model for congenital myasthenia

scientific article published on 09 July 2018

Fast and slow-twitching muscles are differentially affected by reduced cholinergic transmission in mice deficient for VAChT: A mouse model for congenital myasthenia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEUINT.2018.07.002
P932PMC publication ID6421860
P698PubMed publication ID30003945

P50authorCristiane Perácio BastosQ86865600
Cristina GuatimosimQ89012336
Matheus P S Magalhães-GomesQ90024295
P2093author name stringSilvia Guatimosim
Marco A M Prado
Gregorio Valdez
Patrícia M Martinelli
Vânia F Prado
Candido C Coimbra
Daisy Motta-Santos
Grace S Pereira
Jéssica N Andrade
Sydney K Vaughan
Diogo A S Guimarães
Luana P L Schetino
P2860cites workCholine acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humansQ24612220
Cellular and molecular mechanisms of muscle atrophyQ27012762
A new mathematical model for relative quantification in real-time RT-PCRQ27860781
Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic ApneaQ28115635
Transport mechanisms in acetylcholine and monoamine storageQ28139005
Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient miceQ28505352
Roles of neurotransmitter in synapse formation: development of neuromuscular junctions lacking choline acetyltransferaseQ28508674
Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult ratQ28566042
Nerve activity-independent regulation of skeletal muscle atrophy: role of MyoD and myogenin in satellite cells and myonucleiQ28576625
Distinct phenotypes of mutant mice lacking agrin, MuSK, or rapsynQ28584895
Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosisQ28594483
Measuring energy metabolism in the mouse - theoretical, practical, and analytical considerationsQ28703778
The vesicular acetylcholine transporter is required for neuromuscular development and functionQ30436632
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failureQ33725534
Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporterQ33836058
Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathyQ34146828
Retrograde influence of muscle fibers on their innervation revealed by a novel marker for slow motoneuronsQ34164858
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1Q34200869
Shared resistance to aging and ALS in neuromuscular junctions of specific musclesQ34224953
Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysisQ34243643
Analysis of neurotrophic factors in limb and extraocular muscles of mouse model of amyotrophic lateral sclerosisQ34343728
Development of the neuromuscular junction: genetic analysis in miceQ77468492
On the contraction of muscle, chiefly in relation to the presence of "receptive" substances: Part IQ80321879
The proprioceptive and agonist roles of gastrocnemius, soleus and tibialis anterior muscles in maintaining human upright postureQ83482138
An age-related type IIB to IIX myosin heavy chain switching in rat skeletal muscleQ95816706
Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disabilityQ34777891
Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junctionQ35048052
Aging of skeletal muscle fibersQ35554933
Graded Maximal Exercise Testing to Assess Mouse Cardio-Metabolic PhenotypesQ35918375
A hitchhiker's guide to behavioral analysis in laboratory rodents.Q36471789
Inherited disorders of the neuromuscular junctionQ36540407
Progressive Cl- channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington's miceQ37565636
Presynaptic receptors in the neuromuscular junctionQ37601848
Understanding mitochondrial complex I assembly in health and diseaseQ37933572
Fiber types in mammalian skeletal musclesQ37947567
Regulation of cholinergic activity by the vesicular acetylcholine transporterQ38081512
Mechanisms for fiber-type specificity of skeletal muscle atrophyQ38089508
Neuromuscular synaptogenesis: coordinating partners with multiple functionsQ38286009
Modulation of neurotransmitter release by presynaptic autoreceptorsQ38357259
Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptorsQ38368518
Splicing regulation and dysregulation of cholinergic genes expressed at the neuromuscular junction.Q39078041
Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndromeQ39201011
Cholinergic/glutamatergic co-transmission in striatal cholinergic interneurons: new mechanisms regulating striatal computationQ39250067
Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the ratQ40416447
Effects of ageing on the motor unit.Q40448741
Effects of age and training on skeletal muscle physiology and performanceQ40792792
Obesity, Inflammation, and Exercise Training: Relative Contribution of iNOS and eNOS in the Modulation of Vascular Function in the Mouse AortaQ41026978
Loss of MUNC13-1 function causes microcephaly, cortical hyperexcitability, and fatal myastheniaQ41055450
Effects of oxotremorine demonstrate presynaptic muscarinic and dopaminergic receptors on motor nerve terminalsQ41644722
Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulationQ41868301
Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndromeQ42060267
Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome.Q42113919
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin LigasesQ42360652
Congenital myasthenic syndrome associated with episodic apnea and sudden infant deathQ44063736
Three myosin heavy chain isoforms in type 2 skeletal muscle fibres.Q44241210
Skeletal muscle atrophy in old rats: differential changes in the three fiber typesQ44666713
IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.Q44853225
Denervation effects on myonuclear domain size of rat diaphragm fibersQ46892924
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognitionQ48430459
Vesicular acetylcholine transporter knock down-mice are more susceptible to inflammation, c-Fos expression and sickness behavior induced by lipopolysaccharideQ48736335
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in miceQ48941763
Differential effects of age on motor performance in two mouse strainsQ49135939
Adaptations of diaphragm and medial gastrocnemius muscles to inactivityQ51693058
Mutation of the IIB myosin heavy chain gene results in muscle fiber loss and compensatory hypertrophy.Q52141003
Myosin heavy chain composition of muscle fibers in spinal muscular atrophy.Q52248379
How chromosomal deletions can unmask recessive mutations? Deletions in 10q11.2 associated with CHAT or SLC18A3 mutations lead to congenital myasthenic syndrome.Q52790594
Myostatin dysfunction is associated with reduction in overload induced hypertrophy of soleus muscle in mice.Q52862926
Muscle fiber types: how many and what kind?Q54171280
Thyroid hormone regulation of myosin heavy chain isoform composition in young and old rats, with special reference to IIX myosinQ57973347
Satellite cells of the rat soleus muscle in the process of compensatory hypertrophy combined with denervationQ66955672
THE DEVELOPMENT OF ACETYLCHOLINE SENSITIVITY IN NERVE-FREE SEGMENTS OF SKELETAL MUSCLEQ76849791
P921main subjectvertical transmissionQ2834381
P304page(s)1-12
P577publication date2018-07-09
P1433published inNeurochemistry InternationalQ7002160
P1476titleFast and slow-twitching muscles are differentially affected by reduced cholinergic transmission in mice deficient for VAChT: A mouse model for congenital myasthenia
P478volume120

Reverse relations

Q90732350Attenuating Cholinergic Transmission Increases the Number of Satellite Cells and Preserves Muscle Mass in Old Agecites workP2860

Search more.